Second Sight Medical Products: Clinical Trials

11 trials sponsored by Second Sight Medical Products, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 1 active not recruiting, 1 suspended. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Active not recruiting 1, Withdrawn 1

Follow Second Sight Medical Products: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
Blindness, Acquired
SuspendedSecond Sight Medical Products32020-03-062023-11-22
Argus II Retinal Prosthesis System - Better Vision RP Study
Argus II Retinal Prosthesis - Retinitis Pigmentosa
Not applicableWithdrawnSecond Sight Medical Products2018-11-012019-06-25
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
Orion Visual Cortical Prosthesis System - Blindness, Acquired
Not applicableActive not recruitingSecond Sight Medical Products62017-11-202025-01-27
Argus II/ORCAM Device Study
Argus II Eyeglasses, ORCAM - Retinitis Pigmentosa
Not applicableCompletedMayo Clinic42017-08-312022-01-13
Object Finder for a Retinal Prosthesis
Object recognition subsystem - Retinitis Pigmentosa
Not applicableCompletedMinnesota HealthSolutions92017-07-012024-10-15
Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol
Effect of Argus II on Functional Vision - Age Related Macular Degeneration
Not applicableCompletedSecond Sight Medical Products52015-06-012020-03-18
Post-Market Study of the Argus® II Retinal Prosthesis System - France
Argus II Retinal Prosthesis System - Retinitis Pigmentosa
CompletedSecond Sight Medical Products182014-11-202020-06-22
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
Retinitis Pigmentosa
TerminatedSecond Sight Medical Products532014-01-012021-12-23
Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Outer Retinal Degeneration, Retinitis Pigmentosa
TerminatedSecond Sight Medical Products522011-11-012020-05-21
Argus® II Retinal Stimulation System Feasibility Protocol
Implant of Argus II Retinal Prosthesis - Retinitis Pigmentosa
Not applicableCompletedSecond Sight Medical Products302006-09-012022-01-20
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Argus 16 Retinal Stimulation System - Retinitis Pigmentosa
Not applicableCompletedSecond Sight Medical Products62002-02-272023-04-12

Conditions studied

Retinitis Pigmentosa (8)  ·  Blindness (2)  ·  Macular Degeneration (1)

Countries

United States (7)  ·  France (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Italy (1)  ·  Mexico (1)  ·  Switzerland (1)

Top investigators

Anne-Marie Ripley (2)  ·  Jessy Dorn, PhD (2)  ·  Uday Patel, PhD (2)  ·  Gislin Dagnelie, PhD (1)  ·  Lisa Olmos, MD (1)  ·  Peter Walter, Prof Dr med (1)  ·  Pierre-Olivier Barale, MD (1)  ·  Raymond Iezzi (1)

Results publications

PMID 22761263, PMID 29940167, PMID 32131056, PMID 18515576, PMID 19098313, PMID 19365014, PMID 19608533, PMID 20720224, PMID 20881025, PMID 21296811, PMID 22110084, PMID 22244176, PMID 22447863, PMID 22661464, PMID 23500412, PMID 23544203, PMID 23611993, PMID 24013578, PMID 24049718, PMID 25414187, PMID 25432093, PMID 31145440, PMID 32413298, PMID 34706764

NIH funding

5UH3NS103442 (1)